Sfoglia per Autore
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12 engineered allogeneic cell vaccine
2004 DE GIOVANNI C; NICOLETTI G; LANDUZZI L; ASTOLFI A; CROCI S; COMES A; FERRINI S; MEAZZA R; IEZZI M; DI CARLO E; MUSIANI P; CAVALLO F; NANNI P.; LOLLINI P-L
Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells
2004 CROCI S; LANDUZZI L; ASTOLFI A; NICOLETTI G; ROSOLEN A; SARTORI F; FOLLO MY; OLIVER N; DE GIOVANNI C; NANNI P.; LOLLINI P-L
Isolation and in vitro differentiation of human Mesenchymal Stem Cells from new alternative sources: fetal membranes and placenta
2004 Fossati V.; Pierdomenico L.; Alviano F.; Arpinati M.; Marchionni C.; Franchina M.;Croci S.; Bonsi L.; Cantore A.; Lanzoni G.; Bagnara GP
Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity.
2004 DE GIOVANNI C.; LANDUZZI L.; NICOLETTI G.; ASTOLFI A.; CROCI S.; MICARONI M.; NANNI P.; LOLLINI P. L.
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent
2004 NANNI P.; LANDUZZI L; NICOLETTI G; DE GIOVANNI C; ROSSI I; CROCI S; ASTOLFI A; IEZZI M; DI CARLO E; MUSIANI P; FORNI G; LOLLINI P-L
Immunological prevention of a multigene cancer syndrome
2004 CROCI S; NICOLETTI G; LANDUZZI L; DE GIOVANNI C; ASTOLFI A; MARINI C; DI CARLO E; MUSIANI P; FORNI G; NANNI P.; LOLLINI P-L
Expression of T cell receptor alpha gene (TCRA) in human rhabdomyosarcoma and other musculo-skeletal sarcomas.
2005 Croci S; Strippoli P; Bonsi L; Bagnara GP; Guizzunti G; Sartini R; Tonelli R; Messina C; Pierdomenico L; Lollini PL.
Toward the definition of immunosuppressive regimens with antitumor activity.
2005 Casadio F; Croci S; D'Errico Grigioni A; Corti B; Grigioni WF; Landuzzi L; Lollini PL.
Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors.
2005 Scotlandi K; Manara MC; Nicoletti G; Lollini PL; Lukas S; Benini S; Croci S; Perdichizzi S; Zambelli D; Serra M; Garcia-Echeverria C; Hofmann F; Picci P.
Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma.
2005 Astolfi A; Landuzzi L; Nicoletti G; De Giovanni C; Croci S; Palladini A; Ferrini S; Iezzi M; Musiani P; Cavallo F; Forni G; Nanni P; Lollini PL.
Endothelin-3 production by human rhabdomyosarcoma: A possible new marker with a paracrine role.
2006 A. Palladini; A. Astolfi; S. Croci; C. De Giovanni; G. Nicoletti; A. Rosolen; F. Sartori; P.-L. Lollini; L. Landuzzi; P. Nanni
Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells
2007 S. Croci; G. Nicoletti; L. Landuzzi; A. Palladini; F. Chiarini; P. Nanni; P.L. Lollini; C. De Giovanni.
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis.
2007 C. De Giovanni; S. Croci; G. Nicoletti; L. Landuzzi; A. Palladini; T. Pannellini; L. Borgia; M. Iezzi; E. Di Carlo; A.M. Orengo; R.C. Kennedy; P. L. Lollini; P. Nanni; P. Musiani.
Antimetastatic activity of a preventive cancer vaccine.
2007 P. Nanni; G. Nicoletti; A. Palladini; S. Croci; A. Murgo; A. Antognoli; L. Landuzzi; M. Fabbi; S. Ferrini; P. Musiani; M. Iezzi; C. De Giovanni; P.L. Lollini.
Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis.
2007 S. Croci; L. Landuzzi; G. Nicoletti; A. Palladini; A. Antognoli; C. De Giovanni; P. Nanni; P.L. Lollini.
Translational immunomics of cancer prevention.
2009 G. Nicoletti; A. Palladini; A. Murgo; A. Antognoli; S. Croci; F. Pappalardo; S. Motta; P.-L. Lollini
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy
2009 C. De Giovanni; G. Nicoletti; L. Landuzzi; S. Croci; A. Palladini; A. Antognoli; A. Murgo; M.L. Ianzano; V. Grosso; V. Stivani; M. Iezzi; P. Musiani; P. Nanni; P.-L. Lollini
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome
2009 C. De Giovanni; G. Nicoletti; A. Palladini; S. Croci; L. Landuzzi; A. Antognoli; A. Murgo; A. Astolfi; S. Ferrini; M. Fabbi; A.M. Orengo; A. Amici; M. L. Penichet; L. Aurisicchio; M. Iezzi; P. Musiani; P. Nanni; P.-L. Lollini.
Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4.
2009 P. Nanni; G. Nicoletti; A. Palladini; A. Astolfi; P. Rinella; S. Croci; L. Landuzzi; G. Monduzzi; V. Stivani; A. Antognoli; A. Murgo; M.L. Ianzano; C. De Giovanni; P.-L. Lollini.
Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells.
2009 Menotti L.; Nicoletti G.; Gatta V.; Croci S.; Landuzzi L.; De Giovanni C.; Nanni P.; Lollini P.L.; Campadelli-Fiume G.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12 engineered allogeneic cell vaccine | DE GIOVANNI C; NICOLETTI G; LANDUZZI L; ASTOLFI A; CROCI S; COMES A; FERRINI S; MEAZZA R; IEZZI M...; DI CARLO E; MUSIANI P; CAVALLO F; NANNI P.; LOLLINI P-L | 2004-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells | CROCI S; LANDUZZI L; ASTOLFI A; NICOLETTI G; ROSOLEN A; SARTORI F; FOLLO MY; OLIVER N; DE GIOVANN...I C; NANNI P.; LOLLINI P-L | 2004-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Isolation and in vitro differentiation of human Mesenchymal Stem Cells from new alternative sources: fetal membranes and placenta | Fossati V.; Pierdomenico L.; Alviano F.; Arpinati M.; Marchionni C.; Franchina M.;Croci S.; Bonsi... L.; Cantore A.; Lanzoni G.; Bagnara GP | 2004-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
| Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity. | DE GIOVANNI C.; LANDUZZI L.; NICOLETTI G.; ASTOLFI A.; CROCI S.; MICARONI M.; NANNI P.; LOLLINI P.... L. | 2004-01-01 | INTERNATIONAL JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent | NANNI P.; LANDUZZI L; NICOLETTI G; DE GIOVANNI C; ROSSI I; CROCI S; ASTOLFI A; IEZZI M; DI CARLO ...E; MUSIANI P; FORNI G; LOLLINI P-L | 2004-01-01 | JOURNAL OF IMMUNOLOGY | - | 1.01 Articolo in rivista | - |
| Immunological prevention of a multigene cancer syndrome | CROCI S; NICOLETTI G; LANDUZZI L; DE GIOVANNI C; ASTOLFI A; MARINI C; DI CARLO E; MUSIANI P; FORN...I G; NANNI P.; LOLLINI P-L | 2004-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Expression of T cell receptor alpha gene (TCRA) in human rhabdomyosarcoma and other musculo-skeletal sarcomas. | Croci S; Strippoli P; Bonsi L; Bagnara GP; Guizzunti G; Sartini R; Tonelli R; Messina C; Pierdome...nico L; Lollini PL. | 2005-01-01 | GENE | - | 1.01 Articolo in rivista | - |
| Toward the definition of immunosuppressive regimens with antitumor activity. | Casadio F; Croci S; D'Errico Grigioni A; Corti B; Grigioni WF; Landuzzi L; Lollini PL. | 2005-01-01 | TRANSPLANTATION PROCEEDINGS | - | 1.01 Articolo in rivista | - |
| Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors. | Scotlandi K; Manara MC; Nicoletti G; Lollini PL; Lukas S; Benini S; Croci S; Perdichizzi S; Zambe...lli D; Serra M; Garcia-Echeverria C; Hofmann F; Picci P. | 2005-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma. | Astolfi A; Landuzzi L; Nicoletti G; De Giovanni C; Croci S; Palladini A; Ferrini S; Iezzi M; Musi...ani P; Cavallo F; Forni G; Nanni P; Lollini PL. | 2005-01-01 | THE AMERICAN JOURNAL OF PATHOLOGY | - | 1.01 Articolo in rivista | - |
| Endothelin-3 production by human rhabdomyosarcoma: A possible new marker with a paracrine role. | A. Palladini; A. Astolfi; S. Croci; C. De Giovanni; G. Nicoletti; A. Rosolen; F. Sartori; P.-L. L...ollini; L. Landuzzi; P. Nanni | 2006-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cells | S. Croci; G. Nicoletti; L. Landuzzi; A. Palladini; F. Chiarini; P. Nanni; P.L. Lollini; C. De Gio...vanni. | 2007-01-01 | ONCOLOGY REPORTS | - | 1.01 Articolo in rivista | - |
| Inhibition of prostate carcinogenesis by combined active immunoprophylaxis. | C. De Giovanni; S. Croci; G. Nicoletti; L. Landuzzi; A. Palladini; T. Pannellini; L. Borgia; M. I...ezzi; E. Di Carlo; A.M. Orengo; R.C. Kennedy; P. L. Lollini; P. Nanni; P. Musiani. | 2007-01-01 | INTERNATIONAL JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Antimetastatic activity of a preventive cancer vaccine. | P. Nanni; G. Nicoletti; A. Palladini; S. Croci; A. Murgo; A. Antognoli; L. Landuzzi; M. Fabbi; S.... Ferrini; P. Musiani; M. Iezzi; C. De Giovanni; P.L. Lollini. | 2007-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesis. | S. Croci; L. Landuzzi; G. Nicoletti; A. Palladini; A. Antognoli; C. De Giovanni; P. Nanni; P.L. L...ollini. | 2007-01-01 | PATHOLOGY ONCOLOGY RESEARCH | - | 1.01 Articolo in rivista | - |
| Translational immunomics of cancer prevention. | G. Nicoletti; A. Palladini; A. Murgo; A. Antognoli; S. Croci; F. Pappalardo; S. Motta; P.-L. Lollini | 2009-01-01 | - | Springer | 2.01 Capitolo / saggio in libro | - |
| Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy | C. De Giovanni; G. Nicoletti; L. Landuzzi; S. Croci; A. Palladini; A. Antognoli; A. Murgo; M.L. I...anzano; V. Grosso; V. Stivani; M. Iezzi; P. Musiani; P. Nanni; P.-L. Lollini | 2009-01-01 | VACCINE | - | 1.01 Articolo in rivista | - |
| A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome | C. De Giovanni; G. Nicoletti; A. Palladini; S. Croci; L. Landuzzi; A. Antognoli; A. Murgo; A. Ast...olfi; S. Ferrini; M. Fabbi; A.M. Orengo; A. Amici; M. L. Penichet; L. Aurisicchio; M. Iezzi; P. Musiani; P. Nanni; P.-L. Lollini. | 2009-01-01 | HUMAN GENE THERAPY | - | 1.01 Articolo in rivista | - |
| Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4. | P. Nanni; G. Nicoletti; A. Palladini; A. Astolfi; P. Rinella; S. Croci; L. Landuzzi; G. Monduzzi;... V. Stivani; A. Antognoli; A. Murgo; M.L. Ianzano; C. De Giovanni; P.-L. Lollini. | 2009-01-01 | MOLECULAR CANCER THERAPEUTICS | - | 1.01 Articolo in rivista | - |
| Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cells. | Menotti L.; Nicoletti G.; Gatta V.; Croci S.; Landuzzi L.; De Giovanni C.; Nanni P.; Lollini P.L....; Campadelli-Fiume G. | 2009-01-01 | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile